MedPath

Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer

Phase 2
Completed
Conditions
Kidney Cancer
Registration Number
NCT00005045
Lead Sponsor
Eastern Cooperative Oncology Group
Brief Summary

RATIONALE: Carboxyamidotriazole may stop the growth of kidney cancer by stopping blood flow to the tumor.

PURPOSE: Phase II trial to study the effectiveness of carboxyamidotriazole in treating patients who have advanced kidney cancer that has not responded to biological therapy.

Detailed Description

OBJECTIVES: I. Determine the disease free progression at 6 months in patients with locally recurrent or metastatic renal cell cancer (refractory to immunotherapy) treated with carboxyamidotriazole. II. Evaluate the progression free survival rate and response rate in these patients on this regimen. III. Evaluate the toxic effect of this regimen on these patients.

OUTLINE: Patients receive oral carboxyamidotriazole daily. Treatment repeats every 28 days in the absence of disease progression or unacceptable toxicity. Patients with stable disease may discontinue therapy after 6 courses. Patients are followed every 3 months for 2 years, every 6 months for 3 years, and every 12 months thereafter until death.

PROJECTED ACCRUAL: A total of 55 patients will be accrued for this study within 20 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (55)

CCOP - Scottsdale Oncology Program

πŸ‡ΊπŸ‡Έ

Scottsdale, Arizona, United States

Beckman Research Institute, City of Hope

πŸ‡ΊπŸ‡Έ

Los Angeles, California, United States

Veterans Affairs Medical Center - Palo Alto

πŸ‡ΊπŸ‡Έ

Palo Alto, California, United States

Stanford University Medical Center

πŸ‡ΊπŸ‡Έ

Stanford, California, United States

CCOP - Colorado Cancer Research Program, Inc.

πŸ‡ΊπŸ‡Έ

Denver, Colorado, United States

CCOP - Christiana Care Health Services

πŸ‡ΊπŸ‡Έ

Wilmington, Delaware, United States

Walter Reed Army Medical Center

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Veterans Affairs Medical Center - Gainsville

πŸ‡ΊπŸ‡Έ

Gainesville, Florida, United States

Sylvester Cancer Center, University of Miami

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

Scroll for more (45 remaining)
CCOP - Scottsdale Oncology Program
πŸ‡ΊπŸ‡ΈScottsdale, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.